TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03860038 · COMPLETED
Trial details
- NCT number
- NCT03860038
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2023-01-28
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.